These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33317342)

  • 1. Needle-free jet injection of insulin glargine improves glycemic control in patients with type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
    Kong X; Luo M; Cai L; Zhang P; Yan R; Hu Y; Li H; Ma J
    Expert Opin Drug Deliv; 2021 May; 18(5):635-641. PubMed ID: 33317342
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of glucose variability in patients with type 2 diabetes administrated glargine with needle-free jet injector and conventional insulin pen.
    Sun Y; Wang J; Li H; Sun X; Su X; Ma J
    Expert Opin Drug Deliv; 2020 May; 17(5):713-717. PubMed ID: 32141347
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of a needle-free injector in Chinese patients with type 2 diabetes mellitus treated with basal insulin: a multicentre, prospective, randomised, crossover study.
    Xing Y; Xie X; Xu J; Liu J; He Q; Yang W; Zhang N; Li X; Wang L; Fu J; Zhou J; Gao B; Ming J; Liu X; Lai J; Liu T; Shi M; Ji Q
    Expert Opin Drug Deliv; 2019 Sep; 16(9):995-1002. PubMed ID: 31359813
    [No Abstract]   [Full Text] [Related]  

  • 4. Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes.
    Engwerda EE; Tack CJ; de Galan BE
    Diabetes Care; 2013 Nov; 36(11):3436-41. PubMed ID: 24089542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical observation study on the effect of needle-free insulin syringe on blood glucose control and well-being index in patients with early-onset type 2 diabetes mellitus.
    Jin X; Sun Q; Yue C; Han J; Zhou X; Guan Q; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1137179. PubMed ID: 36864833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial.
    Iuchi H; Sakamoto M; Matsutani D; Suzuki H; Horiuchi R; Utsunomiya K
    Diabetes Technol Ther; 2017 Aug; 19(8):457-462. PubMed ID: 28605286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients.
    Guo L; Xiao X; Sun X; Qi C
    Medicine (Baltimore); 2017 Jan; 96(1):e5482. PubMed ID: 28072690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study.
    Takeishi S; Tsuboi H; Takekoshi S
    J Diabetes Investig; 2018 Jan; 9(1):91-99. PubMed ID: 28371461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes.
    Pohlmeier H; Berard L; Brulle-Wohlhueter C; Wu J; Dahmen R; Nowotny I; Klonoff D
    J Diabetes Sci Technol; 2017 Mar; 11(2):263-269. PubMed ID: 27664062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study).
    Ji L; Chen L; Wang Y; Ma Z; Ran X; Sun Z; Xu X; Wang G; Guo L; Shan Z
    Adv Ther; 2019 Jun; 36(6):1485-1496. PubMed ID: 31004325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study.
    Sun F; Gao B; Yang A; Ren L; Xing Y; Ma K; Tian L; Li S; Heng C; Liu H; Zhou J; Ji Q
    Expert Opin Drug Deliv; 2022 Dec; 19(12):1725-1734. PubMed ID: 36378018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy.
    Yan RN; Cai TT; Jiang LL; Jing T; Cai L; Xie XJ; Su XF; Xu L; He K; Cheng L; Cheng C; Liu BL; Hu Y; Ma JH
    Front Endocrinol (Lausanne); 2022; 13():832102. PubMed ID: 35222287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring.
    Wang H; Zhou Y; Zhai X; Ding B; Jing T; Su X; Li H; Ma J
    Front Endocrinol (Lausanne); 2021; 12():754820. PubMed ID: 34917025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial.
    Wada E; Onoue T; Kobayashi T; Handa T; Hayase A; Ito M; Furukawa M; Okuji T; Okada N; Iwama S; Sugiyama M; Tsunekawa T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Kuwatsuka Y; Ando M; Goto M; Arima H
    BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32518063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.
    Derosa G; Franzetti I; Querci F; Romano D; D'Angelo A; Maffioli P
    Diabetes Obes Metab; 2015 Jun; 17(6):554-559. PubMed ID: 25694300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes.
    Warren ML; Brod M; Håkan-Bloch J; Sparre T; Chaykin LB
    Curr Med Res Opin; 2019 Sep; 35(9):1623-1629. PubMed ID: 30974973
    [No Abstract]   [Full Text] [Related]  

  • 17. Lispro administered by the QS-M Needle-Free Jet Injector generates an earlier insulin exposure.
    Hu J; Shi H; Zhao C; Li X; Wang Y; Cheng Q; Goswami R; Zhen Q; Mei M; Song Y; Yang S; Li Q
    Expert Opin Drug Deliv; 2016 Sep; 13(9):1203-7. PubMed ID: 27267431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.
    Ruiz de Adana MS; Colomo N; Maldonado-Araque C; Fontalba MI; Linares F; García-Torres F; Fernández R; Bautista C; Olveira G; de la Cruz JL; Rojo-Martínez G; Valdés S
    Diabetes Res Clin Pract; 2015 Nov; 110(2):158-65. PubMed ID: 26474657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes.
    de Wit HM; Engwerda EE; Tack CJ; de Galan BE
    Diabetes Obes Metab; 2015 Nov; 17(11):1093-9. PubMed ID: 26259978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of clinical efficacy and economic value in Basalin- and Lantus-treated patients with type 2 diabetes using continuous glucose monitoring system.
    Li HQ; Lu CF; Wang J; Yin GP; Sun R; Xu XH; Liu BL; Li FF; Jing T; Lee KO; Ye L; Ma JH; Su XF
    J Endocrinol Invest; 2018 Feb; 41(2):179-184. PubMed ID: 28643298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.